EDIT vs WTW · rev $32.3M vs P/E 15, rev $9.93B
Editas Medicine Inc (EDIT) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported WTW revenue for 2024-12-31 was $9.93B. Net income was -$88.0M. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
EDIT currently screens at market cap $375.2M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the EDIT and WTW stock pages for the full models.
Not investment advice.